Us Congress 2023-2024 Regular Session

Us Congress House Bill HR1045

Introduced
2/29/24  

Caption

Expressing support for the designation of March 3, 2024, as "National Triple-Negative Breast Cancer Day".

Impact

The intended impact of HR1045 is to encourage public awareness and recognition of triple-negative breast cancer, which accounts for a significant percentage of breast cancer cases and deaths in the United States. By establishing a national day dedicated to this issue, proponents hope to mobilize resources, foster support for research initiatives, and enhance understanding of the needs and experiences of those affected by this aggressive cancer. The resolution represents a step towards better educational outreach and potential legislative action aimed at improving healthcare resources for patients dealing with this diagnosis.

Summary

HR1045 is a resolution in the House of Representatives expressing support for the designation of March 3, 2024, as 'National Triple-Negative Breast Cancer Day'. The resolution highlights the distinct nature of triple-negative breast cancer, which is characterized by the absence of three common receptors found in other breast cancers. This type of cancer typically affects young women, as well as Black and Hispanic women, and is known for its aggressive form and high recurrence rate. The resolution aims to raise awareness about the specific challenges posed by this variant of breast cancer, as well as the gaps in targeted therapies available for affected individuals.

Contention

While HR1045 is largely a supportive resolution without contentious provisions, it may face varying levels of support among different legislators. Some representatives might question the need for specific awareness days given the broader context of cancer awareness efforts. However, the focus on a specific and at times overlooked type of breast cancer emphasizes a need for targeted discussion and action, aimed at addressing the unique challenges presented by triple-negative variants. The lack of targeted therapies also highlights an area of concern that advocates for research funding may seek to address through subsequent legislative proposals.

Companion Bills

US HR172

Same As Expressing support for designation of March 3, 2023, as "National Triple-Negative Breast Cancer Day".

Previously Filed As

US HR182

Expressing support for the designation of March 3, 2025, as "National Triple-Negative Breast Cancer Day".

US HR172

Expressing support for designation of March 3, 2023, as "National Triple-Negative Breast Cancer Day".

US HR1000

Expressing support for the designation of February 4, 2024, as "National Cancer Prevention Day".

US HR1050

Supporting the designation of March 2024 as National Colorectal Cancer Awareness Month.

US HR1595

Expressing support for the designation of November 2024 as "National Lung Cancer Awareness Month" and expressing support for early detection and treatment of lung cancer.

US HR221

Expressing support for designation of March 14, 2025, as "National Pi Day".

US HR1508

Supporting the designation of September 2024 as "National Ovarian Cancer Awareness Month".

US HR1077

Expressing support for the designation of the third week of March 2024 as "National CACFP Week".

US HR1044

Expressing support for the designation of February 2024 as "National Youth Leadership Month".

US HR1004

Expressing support for the designation of February 4 through February 10, 2024, as "National Burn Awareness Week".

Similar Bills

No similar bills found.